Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of intravenous Monofer for anemia in palliative upper gastrointestinal adenocarcinoma
2013-000209-22Phase 4Completed
- Sponsor
- Nottingham University Hospitals NHS Trust (Research & Innovation)
- Start
- May 2013
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Nottingham University Hospitals NHS Trust (Research & Innovation). Primary endpoint: Feasibility of a larger trial. Started May 2013; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2013-000209-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000209-22.